2009
DOI: 10.1016/j.chemolab.2009.04.013
|View full text |Cite
|
Sign up to set email alerts
|

Monitoring kidney-transplant patients using metabolomics and dynamic modeling

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
16
0

Year Published

2010
2010
2017
2017

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 26 publications
(16 citation statements)
references
References 16 publications
0
16
0
Order By: Relevance
“…Consequently, there is increasing interest in applying metabolomics during=after clinical organ transplantation for monitoring kidney, heart, and liver (Sarwal, 2009;Wishart, 2005). Examples include a successful attempt to detect acute cardiac rejection by analyzing plasma by proton nuclear magnetic resonance (NMR) spectroscopy (Eugene et al, 1991;Mouly-Bandini et al, 2000); profiling acute renal rejection by gas-chromatography mass spectrometry (Mao et al, 2008); and monitoring kidney transplant patients' immune responses and drug effects in early recovery using urine samples analyzed by NMR (Stenlund et al, 2009). In liver transplantation, NMR-based metabolomics studies have showed that individual metabolites may act as indicators of liver function: for example, primary graft dysfunction may be characterized by constant levels of glycerophosphocholine (in the liver tissue) throughout OLT (Duarte et al, 2005), by increased glutamine levels (serum and urine), and by decreased urea levels (urine) following OLT (Singh et al, 2003).…”
Section: Introductionmentioning
confidence: 99%
“…Consequently, there is increasing interest in applying metabolomics during=after clinical organ transplantation for monitoring kidney, heart, and liver (Sarwal, 2009;Wishart, 2005). Examples include a successful attempt to detect acute cardiac rejection by analyzing plasma by proton nuclear magnetic resonance (NMR) spectroscopy (Eugene et al, 1991;Mouly-Bandini et al, 2000); profiling acute renal rejection by gas-chromatography mass spectrometry (Mao et al, 2008); and monitoring kidney transplant patients' immune responses and drug effects in early recovery using urine samples analyzed by NMR (Stenlund et al, 2009). In liver transplantation, NMR-based metabolomics studies have showed that individual metabolites may act as indicators of liver function: for example, primary graft dysfunction may be characterized by constant levels of glycerophosphocholine (in the liver tissue) throughout OLT (Duarte et al, 2005), by increased glutamine levels (serum and urine), and by decreased urea levels (urine) following OLT (Singh et al, 2003).…”
Section: Introductionmentioning
confidence: 99%
“…Dynamic modelling , Stenlund et al, 2009) is a methodology that makes it possible to evaluate and handle different types of variations such as individual differences in metabolic kinetics, circadian rhythm, fast and slow responders and is also capable of handling sparse and unevenly sampled time series.…”
Section: Orthogonal Projections To Latent Structures Discriminant Anamentioning
confidence: 99%
“…We therefore used PCA to map the metabolic trajectory for each individual rat in accordance with the dynamic modeling approach , Stenlund et al, 2009). This means that each rat is used as its own reference, allowing subtle changes, specific to each individual rat over time to be examined.…”
Section: Comparison Of Serum Profiles Using Pca and Dynamic Modelingmentioning
confidence: 99%
See 1 more Smart Citation
“…9,10 Metabonomics is also considered as a useful tool for surgeons 11 and monitoring renal transplants early and sensitively. [12][13][14][15][16][17][18] Serkova et al found that allantoin and trimethylamine-N-oxide could be used to quantify the severity of ischemia/reperfusion injury in a rat kidney transplant model based on NMR metabolic signatures. 12 By using a matrix assisted laser desorption-ionization Fourier transform mass spectrometer (MALDI-FTMS) Wang et al found that urinary small molecules were associated with acute renal allograft rejection.…”
Section: Introductionmentioning
confidence: 99%